Defence Therapeutics Inc.
DTC
Clasificación en acciones
#29262
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Precio por acción
$0.26788696
Capitalización bursátil
$20.30M
Cambio (1 día)
-3.95%
Cambio (1 año)
-54.23%
País
CA
Comercio Defence Therapeutics Inc. (DTC)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Defence Therapeutics Inc. (DTC)
La acción Defence Therapeutics Inc. (símbolo: DTC) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción DTC comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones DTC.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción DTC comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones DTC.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
